磁共振神经成像生物标志物表征AL型淀粉样变性周围神经病变
该前瞻性研究纳入20例AL型多发性神经病患者和25名年龄性别匹配的健康志愿者,采用3.0T磁共振神经成像检测并量化周围神经病变,并与临床和电生理结果关联。研究发现神经T2加权信号、质子自旋密度、T2弛豫时间和神经横截面积等指标与疾病严重程度相关,提示这些定量参数可作为早期AL型多发性神经病的影像生物标志物。
要点
- 磁共振神经成像可检测并量化AL型多发性神经病的周围神经损伤,敏感度高。
- 神经T2加权信号和质子自旋密度在轻度和中度患者中均高于健康对照。
- T2弛豫时间和胫神经横截面积仅在中度患者中显著升高。
核心结论
- 磁共振神经成像能在活体中高灵敏度地检测并量化AL型多发性神经病的周围神经损伤,且与临床分期密切相关。
- 定量参数是检测早期AL型多发性神经病的可行影像生物标志物,并可能有助于监测治疗过程中的神经组织微结构变化。
研究设计与样本
- 前瞻性研究纳入20例AL型多发性神经病患者和25名年龄、性别匹配的健康志愿者。
- 患者组经详细神经学和电生理检查后分为轻度与中度多发性神经病。
- 采用3.0T磁共振神经成像,解剖覆盖从腰骶丛和近端大腿至胫距关节,使用T2加权和双回波二维序列(频谱脂肪饱和)及三维T2加权反转恢复序列。
- 评估神经T2加权信号,并进行形态学(神经横截面积)和微结构磁共振神经成像标志物(质子自旋密度、T2弛豫时间)的定量分析。
主要发现
- 神经T2加权信号升高与疾病严重程度相关:中度组420.2 ± 60.1 vs 轻度组307.2 ± 17.9(p = 0.0003)vs 对照组207.0 ± 6.4(p < 0.0001)。
- 质子自旋密度在胫神经、腓神经和腓肠神经中,中度组和轻度组均高于对照组(所有神经p < 0.0001);中度组胫神经525.5 ± 53.0、腓神经553.6 ± 64.5、腓肠神经492.0 ± 56.6;轻度组胫神经431.6 ± 22.0、腓神经457.6 ± 21.7、腓肠神经404.8 ± 25.2;对照组胫神经310.5 ± 14.1、腓神经313.6 ± 11.6、腓肠神经261.7 ± 11.0。
- T2弛豫时间仅在中度AL型多发性神经病组升高(胫神经p = 0.0106;腓神经p = 0.0070;腓肠神经p = 0.0190)。
- 胫神经横截面积在中度组(58.0 ± 8.8 mm3)高于轻度组(46.5 ± 2.5 mm3;p = 0.008)和对照组(39.1 ± 1.2 mm3;p < 0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To detect, localize, and quantify peripheral nerve lesions in amyloid light chain (AL) amyloidosis by magnetic resonance neurography (MRN) in correlation with clinical and electrophysiologic findings. METHODS: We prospectively examined 20 patients with AL-polyneuropathy (PNP) and 25 age- and sex-matched healthy volunteers. After detailed neurologic and electrophysiologic testing, the patient group was subdivided into mild and moderate PNP. MRN in a 3.0 tesla scanner with anatomical coverage from the lumbosacral plexus and proximal thigh down to the tibiotalar joint was performed by using T2-weighted and dual-echo 2-dimensional sequences with spectral fat saturation and a 3-dimensional, T2-weighted inversion recovery sequence. Besides evaluation of nerve T2-weighted signal, detailed quantification of nerve injury by morphometric (nerve caliber) and microstructural MRN markers (proton spin density, T2 relaxation time) was conducted. RESULTS: Nerve T2-weighted signal increase correlated with disease severity: moderate (420.2 ± 60.1) vs mild AL-PNP (307.2 ± 17.9; p = 0.0003) vs controls (207.0 ± 6.4; p < 0.0001). Proton spin density was also higher in moderate (tibial: 525.5 ± 53.0; peroneal: 553.6 ± 64.5; sural: 492.0 ± 56.6) and mild AL-PNP (tibial: 431.6 ± 22.0; peroneal: 457.6 ± 21.7; sural: 404.8 ± 25.2) vs controls (tibial: 310.5 ± 14.1; peroneal: 313.6 ± 11.6; sural: 261.7 ± 11.0; p < 0.0001 for all nerves). T2 relaxation time was elevated in moderate AL-PNP only (tibial: p = 0.0106; peroneal: p = 0.0070; sural: p = 0.0190). Tibial nerve caliber was higher in moderate (58.0 ± 8.8 mm3) vs mild AL-PNP (46.5 ± 2.5 mm3; p = 0.008) vs controls (39.1 ± 1.2 mm3; p < 0.0001). CONCLUSIONS: MRN detects and quantifies peripheral nerve injury in AL-PNP in vivo with high sensitivity and in close correlation with the clinical stage. Quantitative parameters are feasible new imaging biomarkers for the detection of early AL-PNP and might help to monitor microstructural nerve tissue changes under treatment.
引用
- Kollmer J, Weiler M, Purrucker J, et al. MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. Neurology. 2018. PMID: 30030328. doi:10.1212/WNL.0000000000006002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。